4.1 Review

Non-invasive EEG evaluation in epilepsy diagnosis

期刊

EXPERT REVIEW OF NEUROTHERAPEUTICS
卷 15, 期 4, 页码 425-444

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1586/14737175.2015.1025382

关键词

EEG; epilepsy; focal; generalized; hyperventilation; medication; photic stimulation; sleep deprivation

资金

  1. Novartis
  2. Pfizer
  3. Eisai
  4. UCB
  5. GSK
  6. Cerbomed
  7. Desitin
  8. Hexal
  9. Medical Tribune
  10. EU
  11. DFG
  12. ESF
  13. CURE-Foundation
  14. DFG [KL 2254/1-1]
  15. University of Melbourne
  16. Janssen-Cilag
  17. GlaxoSmithKline
  18. UCB Pharma

向作者/读者索取更多资源

The EEG is an invaluable tool in the diagnosis of epilepsy which guides clinical management. It helps to determine if attacks are of epileptic origin, allows the estimation of the recurrence risk after a first seizure, aids in the diagnosis of the epilepsy syndrome and represents the gold standard in the presurgical evaluation of epilepsy. The EEG can also detect subclinical seizures as a cause of coma. In this review we discuss the sensitivity and specificity of the EEG, present the EEG findings and their significance in different epilepsy syndromes including focal and generalized epilepsies and describe the application of activation procedures.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据